carbamazepine epoxide has been researched along with Adverse Drug Event in 2 studies
carbamazepine epoxide: metabolite of carbamazepine; RN given refers to unlabeled cpd
carbamazepine-10,11-epoxide : An epoxide and metabolite of carbamazepine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Simper, GS | 1 |
Hò, GT | 1 |
Celik, AA | 1 |
Huyton, T | 1 |
Kuhn, J | 1 |
Kunze-Schumacher, H | 1 |
Blasczyk, R | 1 |
Bade-Döding, C | 1 |
Ram Prabahar, M | 1 |
Raja Karthik, K | 1 |
Singh, M | 1 |
Singh, RB | 1 |
Singh, S | 1 |
Dhamodharan, J | 1 |
1 review available for carbamazepine epoxide and Adverse Drug Event
Article | Year |
---|---|
Successful treatment of carbamazepine poisoning with hemodialysis: a case report and review of the literature.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Fem | 2011 |
1 other study available for carbamazepine epoxide and Adverse Drug Event
Article | Year |
---|---|
Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.
Topics: Allergens; Anticonvulsants; Antigen Presentation; B-Lymphocytes; Binding Sites; Carbamazepine; Cell | 2018 |